Smart Lipo Dietary Supplement Recalled for Undeclared Dangerous Ingredients
Centro Naturista is recalling Smart Lipo Dietary Supplement capsules because they contain undeclared sibutramine, desmethylsibutramine, and phenolphthalein.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 5/5 (Critical).
Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The agency classification is FDA Class I, which indicates a reasonable probability that use of or exposure to the violative product will cause serious adverse health consequences or death.
Plain-English summary
Centro Naturista is recalling Smart Lipo Dietary Supplement capsules, 800 mg, packaged in 30-count plastic bottles. The product is distributed by SmartLipo365 in Arlington, TX, and was marketed nationwide. The recall covers all lots of the product.
The FDA is recalling the product because it was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). Additionally, the product contains undeclared sibutramine, desmethylsibutramine, and phenolphthalein. These undeclared ingredients are not approved for use in dietary supplements and can pose serious health risks.
Consumers who have purchased Smart Lipo Dietary Supplement capsules should stop using the product immediately. They should contact the distributor or manufacturer for further instructions on how to return the product or obtain a refund.
The recalled product
- Product
- Smart Lipo Dietary Supplement capsules, 800 mg, packaged in 30-count plastic bottle, Distributed by: SmartLipo365, Arlington, TX 76011
- Manufacturer
- Centro Naturista
- Category
- Drug — Dietary Supplement
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Centro Naturista under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Centro Naturista
See all →- CriticalSmart Lipo Dietary Supplement Recalled for Undeclared Dangerous Ingredients
FDA (Drugs) · 2016-06-01
- ModerateCentro Naturista Recalls Smart Lipo Dietary Supplement Capsules
FDA (Food) · 2016-04-27
Same hazard · undeclared drug ingredients
See all →- CriticalBuy-Herbal Recalls Kian Pee Wan Capsules for Undeclared Drug Ingredients
FDA (Drugs) · 2026-08-19
- SevereDietary Supplement Male Ultra Recalled for Undeclared Drug Ingredients
FDA (Drugs) · 2025-06-18
- CriticalFDA Recalls Rhino 5 Capsules Containing Unapproved Drug Ingredients
FDA (Drugs) · 2014-02-05
- CriticalDietary Supplement Recalled for Undeclared Drug Ingredients
FDA (Drugs) · 2013-05-01
Similar recalls
- ModerateCentro Naturista Recalls Smart Lipo Dietary Supplement Capsules
FDA (Food) · 2016-04-27
- SevereA1 Slim Dietary Supplement Recalled for Undeclared Unapproved Drug Ingredients
FDA (Drugs) · 2017-11-08
- SevereZero Xtreme Dietary Supplement Recalled for Undeclared Sibutramine
FDA (Drugs) · 2018-11-21
- CriticalBotanicalNow BodySlim Herbal Capsules Recalled for Undeclared Sibutramine
FDA (Drugs) · 2018-01-31
- CriticalUltra ZX Dietary Supplement Recalled for Undeclared Sibutramine and Phenolphthalein
FDA (Drugs) · 2015-05-13
- CriticalDietary Supplement Recalled for Undeclared Fluoxetine and Lack of Approval
FDA (Drugs) · 2014-05-07